ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04610	Complement and coagulation cascades	17/29	79/7206	3.57789404302e-27
ko05150	Staphylococcus aureus infection	8/29	36/7206	6.72336977636e-13
ko05322	Systemic lupus erythematosus	6/29	151/7206	2.4445434072e-05
ko05133	Pertussis	4/29	87/7206	0.000373900629234
ko05020	Prion diseases	3/29	40/7206	0.000523926843777
ko05134	Legionellosis	3/29	74/7206	0.00313604047248
ko05140	Leishmaniasis	3/29	75/7206	0.00325791324003
ko04977	Vitamin digestion and absorption	2/29	22/7206	0.003436794168
ko04145	Phagosome	4/29	162/7206	0.0037705222315
ko05168	Herpes simplex infection	4/29	182/7206	0.00570566261841
ko00620	Pyruvate metabolism	2/29	46/7206	0.0145071433072
ko05142	Chagas disease (American trypanosomiasis)	3/29	130/7206	0.0148875919613
ko04611	Platelet activation	3/29	163/7206	0.0269912837437
ko05152	Tuberculosis	3/29	187/7206	0.0383164227702
ko00072	Synthesis and degradation of ketone bodies	1/29	10/7206	0.0395474451342
ko05167	Kaposi's sarcoma-associated herpesvirus infection	3/29	191/7206	0.0404087079139